Held by 2 specialist biotech funds
**Signal Note: Eventide Initiates IDCC Position** InterDigital is a patent licensing and technology company focused on wireless communications standards (5G/6G), not a biotech firm—this appears to be a data classification error or portfolio diversification move by Eventide rather than a core biotech signal. The $1.8M position suggests values-based or ESG screening criteria alignment rather than clinical/pipeline momentum in life sciences.